Status:

COMPLETED

The Use of Belladonna and Opium Suppository in the Treatment of Postoperative Stent Pain

Lead Sponsor:

University of Washington

Conditions:

Nephrolithiasis

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

The purpose of this study is to determine if preemptive B\&O suppository placement will decrease post-operative pain in patients undergoing ureteral stent placement.

Detailed Description

Purpose: Nephrolithiasis has an incidence of 10-15% in the US with 66% of practicing urologists placing a ureteral stent after each procedure. Ureteral stents are commonly placed to prevent or allevia...

Eligibility Criteria

Inclusion

  • patients who will receive ureteroscopy with concurrent placement of a ureteral stent.

Exclusion

  • age \< 18,
  • neurologic deficits of any kind
  • non-English speaking patients.

Key Trial Info

Start Date :

August 1 2013

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 1 2015

Estimated Enrollment :

71 Patients enrolled

Trial Details

Trial ID

NCT03332056

Start Date

August 1 2013

End Date

October 1 2015

Last Update

June 18 2023

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

The Use of Belladonna and Opium Suppository in the Treatment of Postoperative Stent Pain | DecenTrialz